To characterize the role of cardiac function in septic shock, serial radionuclide cineangiographic and hemodynamic evaluations were done on 20 patients with documented septic shock. Although all patients had a normal or elevated cardiac index, 10 patients had moderate to severe depression of their ejection fraction with values below 0.40. Thirteen of twenty patients survived their episode. Paradoxically, 10 of 13 survivors, but none of the 7 nonsurvivors, had an initial ejection fraction less than 0.40 (p < 0.005). The mean initial ejection fraction for the survivors was 0.32 ± 0.04, and their mean end systolic and end diastolic ventricular volumes were substantially increased with a normal stroke volume. The survivors' serial scans showed a gradual return to normal ejection fraction and ventricular volume by 10 days after the onset of shock. Nonsurvivors had normal initial ejection fractions and ventricular volumes that did not change during serial studies.
disorder with a high mortality. Efforts to define the cardiovascular abnormalities that characterize septic shock in humans have focused on both peripheral vascular and cardiac dysfunction (1-13). Myocardial depression, usually defined as a low cardiac index, has been described as a key factor in the pathogenesis of this syndrome. However, the hemodynamic pattern of septic shock in humans, as described in most large series of reported patients, is characterized by a high cardiac index and a low systemic vascular resistance index (2-8, 11, 12). The concept of a low cardiac output due to myocardial depression largely stems from animal models (4, 5) using endotoxin administration that results in a low cardiac output form of shock not at all analogous to that seen in humans. Further evidence for low cardiac output in septic shock stems from anecdotal cases of a falling cardiac output before the death of patients with septic shock (6). However, most patients with septic shock are "hyperdynamic*' with high cardiac outputs, and the cases reported with a low cardiac index may represent the coexistence of septic shock and hypovolemia (3).
In evaluating the ventricular function of patients with coronary artery disease, the ejection fraction has been a more reliable indicator of overall ventricular performance and ultimate prognosis than the cardiac index (14) . We have done serial hemodynamic studies and serial radionuclide cineangiographic studies on patients with septic shock. A previous recent study evaluated patients with sepsis but without shock using radionuclide cineangiography and found that the mean ejection fraction for this group was normal; however, one quarter of these patients had a reduced ejection fraction on a single study (13) . We have evaluated a series of patients with moderate to severe septic shock using radionuclide cineangiography and hemodynamic evaluations. We report the presence of severe, reversible myocardial depression in a substantial proportion of these patients.
Methods
From April to December 1982, 20 patients with septic shock were studied in the medical intensive care unit of the National Institutes of Health. Seventeen patients had a temperature greater than 38 °C, hypotension (mean arterial pressure less than 60 mm Hg), and positive blood cultures. Three patients had fever, hypotension, profound neutropenia (neutrophils less than 500/mm 3 ), and a localized site of infection, but negative blood cultures that were attributed to concomitant broad spectrum antibiotic treatment.
Arterial pressure was monitored by an indwelling arterial catheter in the radial or femoral artery. A Swan-Ganz catheter was positioned with fluoroscopic guidance in the pulmonary artery of each patient. Serial measurements of central venous pressure, pulmonary artery pressure, pulmonary capillary wedge pressure, and cardiac output by the thermodilution technique were obtained. Measurements of pulmonary capillary wedge pressure were done from tracings on graph paper of the pulmonary capillary wedge pressure at end expiration. In patients on positive end expiratory pressure, measurements of pulmonary capillary wedge pressure were made at end expiration both on and after 10 seconds off positive end expiratory pressure. In the patients in this study, the pulmonary capillary wedge pressure on and off positive and expiratory pressure never differed by more than 2 mm Hg.
THERAPEUTIC PROTOCOL
Each patient received the following treatment to maintain a mean arterial pressure greater than 60 mm Hg. Initially, all patients received intravenous fluids to maintain a pulmonary capillary wedge pressure of 12 to 15 mm Hg. Dopamine was then added if the patient remained hypotensive. If the patient required more than 20 fig/kg • min of dopamine, levarterenol was added, and the dopamine was tapered to 2 to 5 /xg/kg. min in an attempt to preserve renal perfusion. All patients received broad-spectrum antibiotic coverage, usually including an aminoglycoside, a cephalosporin, and a semisynthetic penicillin active against Pseudomonas aeruginosa. When blood culture results were obtained, the antibiotic agents were adjusted appropriately. Each patient was given two doses of methylprednisolone, 30 mg/kg body weight, one at the onset of shock, and the second 4 to 8 hours later. Respiratory support was given as needed to maintain a normal pH and an arterial partial pressure of oxygen (P02) greater than 70 mm Hg; all studies were done when arterial P02 and pH were normal. Fifteen patients required mechanical ventilation; the other 5 patients received supplemental oxygen. Metabolic parameters were checked on several occasions daily and abnormalities, especially of potassium, phosphate, and glucose, were corrected promptly.
RADIONUCLIDE CINEANGIOGRAPHY STUDIES
Serial radionuclide cineangiography studies were done on Autopsies were done on six of the seven nonsurvivors; five patients had no coronary artery disease, and one patient had an adequately bypassed coronary stenosis. Two of the survivors later died of causes unrelated to septic shock; neither had significant coronary artery disease seen at autopsy. Table 2 , by chi-squared analysis, this difference between surviving and nonsurviving patients is statistically significant (p< 0.005). Thus, somewhat paradoxically, a low initial ejection fraction is associated with survival. It is of interest that three surviving patients had radionuclide cineangiographic studies done before the onset of septic shock. Two of these patients had previously known heart disease. All three patients had an acute fall in ejection fraction from their baseline values, with full recovery over 7 to 10 days. All of the survivors show a rise in their ejection fraction over the 7 to 10 day period, whereas the nonsurvivors show no consistent change in ejection fraction.
End diastolic and end systolic volume indices were calculated and are plotted against time in Figure 5 . Ejection Regarding afterload, the systemic vascular resistance index has been analyzed above and in Figure 2B . Although the initial systemic vascular resistance index between the survivors and nonsurvivors is not statistically different, when individual patient resistance indices are averaged for the first 4 days and compared, the indices of the nonsurvivors are significantly lower than those of the survivors.
Heart rate was analyzed in the survivors and nonsurvivors. The initial mean heart rate in the nonsurvivors (119 ±5.8 beats/min) is somewhat higher than in the survivors (103 ± 6.3 beats/min) but this difference lacks statistical significance (p > 0.1). When the heart rate of each patient is averaged over the first 4 days of the study, the mean value found, and compared, the nonsurvivors (118 ±5.6 beats/min) and survivors (103 ± 6.8 beats/min) show similar heart rates that are not significantly different (p>0.1).
Because the vasopressors dopamine and levarterenol can affect cardiac contractility and afterload, the doses of We have extensively evaluated a number of factors that are known to effect ejection fraction-preload, afterload, heart rate (15), and positive end expiratory pressureand found that they cannot account for the changes in ejection fraction. The levels of pulmonary capillary wedge pressure, positive end expiratory pressure, and heart rate were the same in both the survivors and nonsurvivors. Afterload, as measured by systemic vascular resistance index, was not significantly different on initial studies; however, when the first 4 days of the study were evaluated, the systemic vascular resistance index in the nonsurvivors was significantly lower than in the survivors (p<0.05). This difference raises the following postulate: all patients with septic shock may develop myocardial depression; however, nonsurvivors have a lower systemic vascular resistance index ( Figure 2B) cardial performance as shown by a low ejection fraction and ventricular dilatation.
In our judgment, the use of dopamine and levarterenol did not explain the low ejection fractions seen in the survivors or the lack of evidence of myocardial depression in the nonsurvivors. Dopamine would be expected to increase myocardial contractility, thus increasing the ejection fraction. In low doses (1 to 5 fxg/kg • min) used in this study, dopamine may also decrease the systemic vascular resistance index, tending to increase the ejection fraction. Eight of the 13 survivors during their initial study were on doses of dopamine that would be expected to increase the ejection fraction; however, 6 of 8 had a profound reduction in the ejection fraction to less than 0.4 and the ejection fraction recovered toward normal values in all surviving patients by 10 days after septic shock. Importantly, five of the 13 survivors were not on dopamine (or any vasopressor) during their initial study, and 4 of 5 had ejection fractions less than 0.4 and all 5 had substantial reductions below their recovery values at 7 to 10 days after shock. The doses of dopamine in the survivors were not significantly different from those of the nonsurvivors and did not correlate with ejection fraction or systemic vascular resistance index. Thus, dopamine does not account for the myocardial depression seen in the survivors.
Two of the seven nonsurvivors during the initial study were not on dopamine (or any pressors) and four others were on less than 10 jug/kg-min of dopamine (a dose comparable to the eight survivors on dopamine), yet these six nonsurvivors all had ejection fractions greater than 0.4 that did not significantly change to within 24 hours of their death. The dopamine dosage in the survivors and nonsurvivors was not significantly different. We conclude that dopamine administration does not account for the normal ejection fractions seen in the nonsurvivors.
The administration of levarterenol would be expected to produce a severe increase in systemic vascular resistance index resulting from alpha-agonist-induced peripheral vasoconstriction and also a modest increase in cardiac contractibility from B\-adrenergic stimulation. The increase in afterload would reduce the ejection fraction. Nine of the thirteen survivors were not on levarterenol at any point in their course, but 7 of these 9 had decreased ejection fractions less than 0.4. All 13 survivors were off levarterenol by 24 hours after septic shock, yet the depressed ejection fraction in the survivors persisted for 4 days (Figure 3) . Thus, levarterenol cannot account for the reduced ejection fraction in the survivors.
In the seven nonsurvivors, the mean dosage of levarterenol was higher than in the survivors; however, the nonsurvivors had lower systemic vascular resistance indices and high ejection fractions. This finding is the opposite of the effect that would have been predicted if levarterenol were accounting for the changes in ejection fraction. One could postulate that the peripheral effects of levarterenol are ineffective in severe septic shock (due perhaps to circulating mediators), and levarterenol-induced increases in cardiac contractility account for the normal ejection fractions of nonsurvivors; that is, all septic shock patients would show initially reduced ejection fraction but the high levarterenol dosage increases the ejection fraction to normal in nonsurvivors. This postulate appears unlikely, however, because three of the seven nonsurvivors were not on levarterenol during their initial study, but all three patients had ejection fractions greater than 0.45. We conclude that levarterenol administration cannot account for the normal ejection fractions in nonsurvivors.
Three patients who ultimately survived had baseline radionuclide cineangiographic studies done within 1 week before the onset of septic shock (Figure 4) . At the onset of shock these three patients had an acute fall in ejection fraction, with a gradual recovery to their baseline level of ventricular function. It is of interest that one of these patients had hypertrophic cardiomyopathy with a resting ejection fraction of 0.83. With the onset of septic shock, the ejection fraction fell to 0.63 ("depressed") with recovery to 0.87 at 10 days after shock. It is likely, therefore, that most of the patients in this study had normal ventricular function before developing septic shock, and that the survivors developed an acute myocardial depression that was reversible. The available autopsy data from this study gives no evidence for unsuspected coronary artery disease or other pathologic findings in patients believed to have normal hearts.
The survivors had acute dilatation of the heart, enabling them to maintain a normal stroke volume and cardiac index, despite a profound loss of myocardial contractility. This finding is shown schematically in Figure 5 . The nonsurvivors did not have this left ventricular dilatation and decrease in ejection fraction, although they also maintained a normal stroke volume and cardiac index. The reason for this seemingly paradoxical result is not known; however, the nonsurvivors had a more severe peripheral vascular defect leading to a somewhat lower systemic vascular resistance index. This action could well result in a more profound capillary leak with increasing edema and multi-organ failure. It is possible that severe myocardial capillary leak and myocardial edema resulted in a loss of myocardial compliance and caused an inability of the left ventricle to dilate. Animal studies have suggested a possible role for myocardial edema in septic shock (20) . The ability of the left ventricle to dilate may be an adaptive response important to the patient with septic shock. The survivors may have less myocardial edema, permitting ventricular dilatation in response to the unknown stimulus causing myocardial depression, and thus maintain cardiac output and survive septic shock.
The patients in our study had similar hemodynamic responses to septic shock produced by different organisms, although the number of patients with gram-positive and fungal sepsis was small. In general, this finding is in agreement with other groups that found that the response to sepsis is similar regardless of the organism (2, 21) . Some authors have argued that gram-negative sepsis produces a different hemodynamic pattern from gram-positive sepsis (10) .
The mechanism of myocardial depression in septic shock has been debated but remains poorly understood.
Although there is some evidence for a humoral myocardial depressant factor in animals (16) (17) (18) , such a substance has never been clearly identified in man. In animal models changes in coronary perfusion have been suggested as a possible cause of myocardial depression in sepsis (22) . Factors such as complement, endorphins, and histamine (23) have also been proposed as possible agents in producing myocardial depression in septic shock. Further studies are needed to elucidate both the mechanisms by which myocardial depression occurs in septic shock and the methods for preventing or reversing this depression.
